Andreas Sourlas

741 total citations
18 papers, 517 citations indexed

About

Andreas Sourlas is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Andreas Sourlas has authored 18 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Andreas Sourlas's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Andreas Sourlas is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Andreas Sourlas collaborates with scholars based in Greece, United States and Cyprus. Andreas Sourlas's co-authors include Constantine E. Kosmas, Eliscer Guzman, Peter D. Montan, Delia Silverio, E Papakonstantinou, Mario J. García, Christina Kostara, Mario J. García, Gordon Mallarkey and Aikaterini Papadimitriou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Medicinal Chemistry and Current Opinion in Lipidology.

In The Last Decade

Andreas Sourlas

18 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Sourlas Greece	12	240	172	117	102	83	18	517
Peter D. Montan United States	11	197 0.8×	163 0.9×	98 0.8×	103 1.0×	69 0.8×	14	492
Anastazia Kei Greece	13	262 1.1×	185 1.1×	114 1.0×	106 1.0×	67 0.8×	34	548
Thomas Dayspring United States	14	342 1.4×	183 1.1×	125 1.1×	84 0.8×	101 1.2×	33	617
Margherita Botta Italy	11	272 1.1×	113 0.7×	74 0.6×	225 2.2×	80 1.0×	17	602
Rafael Bitzur Israel	13	228 0.9×	244 1.4×	87 0.7×	167 1.6×	56 0.7×	30	712
Victoria Marco-Benedí Spain	14	312 1.3×	176 1.0×	98 0.8×	68 0.7×	99 1.2×	54	557
Hironobu Mitani Japan	16	206 0.9×	123 0.7×	99 0.8×	118 1.2×	44 0.5×	27	489
Fabiana Hanna Rached Brazil	10	243 1.0×	235 1.4×	152 1.3×	150 1.5×	81 1.0×	26	545
Delia Silverio United States	9	123 0.5×	82 0.5×	59 0.5×	81 0.8×	38 0.5×	10	301

Countries citing papers authored by Andreas Sourlas

Since Specialization

Citations

This map shows the geographic impact of Andreas Sourlas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Sourlas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Sourlas more than expected).

Fields of papers citing papers by Andreas Sourlas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Sourlas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Sourlas. The network helps show where Andreas Sourlas may publish in the future.

Co-authorship network of co-authors of Andreas Sourlas

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Sourlas. A scholar is included among the top collaborators of Andreas Sourlas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Sourlas. Andreas Sourlas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kosmas, Constantine E., et al.. (2024). Biomarkers of insulin sensitivity/resistance. Journal of International Medical Research. 52(10). 5 indexed citations

Kosmas, Constantine E., et al.. (2023). PCSK9 Targeting in the Management of Hypercholesterolaemia. SHILAP Revista de lepidopterología. 87–97. 4 indexed citations

Kosmas, Constantine E., et al.. (2022). Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia. Clinical Pharmacology Advances and Applications. Volume 14. 49–59. 24 indexed citations

Kosmas, Constantine E., et al.. (2021). New and emerging lipid-modifying drugs to lower LDL cholesterol. Drugs in Context. 10. 1–22. 24 indexed citations

Sourlas, Andreas, et al.. (2021). Inclisiran in dyslipidemia. Drugs of today. 57(5). 311–311. 10 indexed citations

Kostara, Christina, Constantine E. Kosmas, Andreas Sourlas, & Eliscer Guzman. (2021). Environmental Factors Modifying HDL Functionality. Current Medicinal Chemistry. 29(10). 1687–1701. 5 indexed citations

Sourlas, Andreas, et al.. (2020). Safety and Tolerability of PCSK9 Inhibitors: Current Insights. SHILAP Revista de lepidopterología. 21 indexed citations

Kosmas, Constantine E., et al.. (2020). <p>Safety and Tolerability of PCSK9 Inhibitors: Current Insights</p>. Clinical Pharmacology Advances and Applications. Volume 12. 191–202. 28 indexed citations

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, et al.. (2019). Anti-inflammatory therapy for cardiovascular disease. Annals of Translational Medicine. 7(7). 147–147. 49 indexed citations

10.

Montan, Peter D., et al.. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine. 7(16). 393–393. 40 indexed citations

11.

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, Peter D. Montan, & Eliscer Guzman. (2019). Dysfunctional high-density lipoprotein and atherogenesis. Vessel Plus. 2019. 6 indexed citations

12.

Kosmas, Constantine E., Andreas Sourlas, Gordon Mallarkey, et al.. (2019). Therapeutic management of hyperlipoproteinemia (a). Drugs in Context. 8. 1–11. 15 indexed citations

13.

Sourlas, Andreas & Constantine E. Kosmas. (2019). Inheritance of high and low HDL: mechanisms and management. Current Opinion in Lipidology. 30(4). 307–313. 10 indexed citations

14.

Kosmas, Constantine E., et al.. (2018). Primary genetic disorders affecting high density lipoprotein (HDL). Drugs in Context. 7. 1–11. 11 indexed citations

15.

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, Peter D. Montan, & Eliscer Guzman. (2018). Role of spironolactone in the treatment of heart failure with preserved ejection fraction. Annals of Translational Medicine. 6(23). 461–461. 15 indexed citations

16.

Kosmas, Constantine E., et al.. (2018). High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context. 7. 1–9. 159 indexed citations

17.

Kosmas, Constantine E., et al.. (2018). Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus. Drugs in Context. 7. 1–7. 17 indexed citations

18.

Kosmas, Constantine E., et al.. (2018). Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia. SHILAP Revista de lepidopterología. 6(3). 63–63. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact